MUSECHEM: LEADING PROVIDER OF PEPTIDE CHEMICALS AND MORE

The MAPK/ERK signaling pathway is another crucial target for inhibitors. This pathway is entailed in managing cell survival, growth, and distinction. Inhibitors targeting MAPK/ERK are utilized in cancer cells treatments to stop unchecked cell proliferation and tumor development. Likewise, JAK/STAT signaling inhibitors modulate immune feedbacks and